8 Respiratory Conditions Beyond Asthma and Allergies

6. Alpha-1 Antitrypsin Deficiency - The Genetic Protease Imbalance

Alpha-1 antitrypsin deficiency represents a hereditary condition that predisposes individuals to early-onset emphysema and liver disease due to insufficient production of alpha-1 antitrypsin, a protein that protects the lungs from damage by neutrophil elastase. This genetic disorder affects approximately 1 in 2,000-5,000 individuals of European descent but remains significantly underdiagnosed, with studies suggesting that less than 10% of affected individuals have been identified. The condition results from mutations in the SERPINA1 gene, with the most severe deficiency occurring in individuals with the ZZ phenotype. Unlike typical COPD that develops primarily in older smokers, alpha-1 antitrypsin deficiency can cause emphysema in young adults, even in non-smokers, though smoking dramatically accelerates lung destruction. Patients typically present with shortness of breath, reduced exercise tolerance, and recurrent respiratory infections, often in their 30s or 40s. The emphysema characteristically affects the lower lobes of the lungs, in contrast to smoking-related emphysema which predominantly affects the upper lobes. Diagnosis involves measuring serum alpha-1 antitrypsin levels and phenotyping to identify specific genetic variants. Treatment includes standard COPD management with bronchodilators and pulmonary rehabilitation, but uniquely, patients may benefit from augmentation therapy with intravenous alpha-1 antitrypsin derived from human plasma donors. This replacement therapy aims to restore protective levels of the protein in the lungs and slow the progression of emphysema. Genetic counseling is essential for affected families, as the condition follows an autosomal recessive inheritance pattern.